Research Funding

DOD Parkinson’s Research Program Funding Opportunities Fiscal Year 2019

The FY19 Defense Appropriation provides $16 million (M) to the Department of Defense Parkinson’ Research Program (PRP) to support research to understand, prevent, diagnose, and treat Parkinson’s disease.  Applications to the FY19 PRP are being solicited by the U.S. Army Medical Research Acquisition Activity (USAMRAA).  The managing agent for the anticipated Program Announcements/Funding Opportunities is the Congressionally Directed Medical Research Programs (CDMRP) at the U.S. Army Medical Research and Materiel Command (USAMRMC).

FY19 PRP Program Announcements and General Application Instructions for the following award mechanisms are posted on the Grants.gov website.

IMPORTANT:  The PRP seeks to focus applications and direct funding by providing Focus Areas to address the critical needs in Parkinson’s disease research.

https://cdmrp.army.mil/funding/prp

Investigator-Initiated Research Award – Letter of Intent due July 9, 2019

Assistant Professor Level of above (or equivalent)

  • Supports highly rigorous, high-impact research projects that have the potential to make an important contribution to Parkinson’s disease research and/or patient care.
  • Potential impact of research may be near term or long term, but it must be significant and go beyond an incremental advancement.
  • Must address at least one of the Fy19 PRP Focus Areas.
  • Preliminary data to support feasibility are encouraged.
  • Submission of a Letter of Intent is require prior to full application submission.
  • Clinical trials not allowed

Partnering PI Option:

  • Provides a higher level of funding to support synergistic partnerships between two or three independent investigators collaborating on a single application.
  • PIs are expected to demonstrate within the application the synergistic components that will significantly advance the project, such that the research outcomes could not otherwise be accomplished through the independent efforts of a single PI.
  • The proposed partnership should result in a level of productivity that is greater than that achievable by each PI independently.

Individual PI:

  • Maximum funding of $1.5 million (M) for total costs (includes direct and indirect costs)
  • Maximum period of performance years

Partnering PI Option:

  • Maximum funding of $2.4M for total costs (includes direct and indirect costs)
  • Maximum period of performance years

Early Investigator Research Award – Letter of Intent due July 9, 2019

Investigator must be a postdoctoral or clinical fellow, instructor, or assistant professor within 10 years of advanced degree or residency training (or equivalent)

  • Supports early-career investigators exploring innovative, high-impact ideas or new technologies applicable to Parkinson’s disease research and/or patient care.
  • PIs must have a designated mentor who is an experienced Parkinson’s disease researcher.
  • Must address at least one of the FY19 PRP Focus Areas.
  • Preliminary data not required.
  • Submission of a Letter of Intent is required prior to full application submission.
  • Clinical trials not allowed
  • Maximum funding of $360,000 for total costs (includes direct and indirect costs)
  • Maximum period of performance 2 years

A pre-application is required and must be submitted through the electronic Biomedical Research Application Portal (eBRAP) at https://eBRAP.org prior to the pre-application deadline.  All applications must conform to the final Program Announcements and General Application Instructions available for electronic downloading from the Grants.gov website.  The application package containing the required forms for each award mechanism will also be found on Grants.gov.  A listing of all CDMRP and other USAMRMC extramural funding opportunities can be obtained on the Grants.gov website by performing a basic search using CFDA Number 12.420.

For email notification when Program Announcements are released, subscribe to program-specific news and updates under “Email Subscriptions” on the eBRAP homepage at https://eBRAP.org.  For more information about the PRP or other CDMRP-administered programs, please visit the CDMRP website (https://cdmrp.army.mil).

Point of Contact:

CDMRP Help Desk
301-682-5507
help@eBrap.org

Leave a Reply

Time limit is exhausted. Please reload CAPTCHA.